← Back to Search

Behavioural Intervention

Exercise for Sarcopenia

N/A
Waitlist Available
Research Sponsored by Baltimore VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test whether aerobic exercise can help improve muscle mass in older adults with sarcopenia.

Who is the study for?
This trial is for older adults with a body mass index between 18-32.5 who have moderate sarcopenia, which means they've lost muscle mass as they've aged. They must be non-smokers and not currently exercise regularly. People with diabetes, cancer, lung or kidney diseases, or physical impairments that prevent exercising cannot participate.Check my eligibility
What is being tested?
The study is testing if doing aerobic exercises can increase the number of small blood vessels in muscles and improve the benefits of strength training in older adults with sarcopenia to help them regain muscle mass and function.See study design
What are the potential side effects?
Typical side effects from aerobic and strength training may include muscle soreness, fatigue, increased heart rate during exercise, joint stress, or injury if not performed correctly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle Tissue
Skeletal muscle capillarization
Secondary outcome measures
Muscle strength
Skeletal muscle structure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Aerobic exercise training followed by resistance trainingExperimental Treatment2 Interventions
Participants in this arm will undergo 3 months of aerobic exercise training, followed by 3 months of strength training
Group II: Resistance training followed by aerobic exercise trainingActive Control2 Interventions
Participants in this arm will undergo 3 months of strength training, followed by 3 months of aerobic exercise training

Find a Location

Who is running the clinical trial?

Baltimore VA Medical CenterLead Sponsor
32 Previous Clinical Trials
3,093 Total Patients Enrolled
2 Trials studying Sarcopenia
19 Patients Enrolled for Sarcopenia
University of Maryland, BaltimoreOTHER
687 Previous Clinical Trials
374,614 Total Patients Enrolled
3 Trials studying Sarcopenia
267 Patients Enrolled for Sarcopenia

Media Library

Aerobic exercise training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03984994 — N/A
Sarcopenia Research Study Groups: Aerobic exercise training followed by resistance training, Resistance training followed by aerobic exercise training
Sarcopenia Clinical Trial 2023: Aerobic exercise training Highlights & Side Effects. Trial Name: NCT03984994 — N/A
Aerobic exercise training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03984994 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria should applicants meet to be considered for enrolment in this experiment?

"To be included in this medical trial, volunteers must possess sarcopenia and aged between 65 to 88. The research team is aiming to recruit up to 40 participants for the study."

Answered by AI

What is the scope of participants in this clinical trial?

"Indeed, clinicaltrials.gov notes that this medical experiment is currently looking for participants. It was originally posted on March 15th 2020 and updated as recently as February 28th 2022. 40 individuals are needed between two separate sites to take part in the trial."

Answered by AI

Is there any age restriction on applicants for this experiment?

"Subjects aged between 65 and 88 are invited to enrol in this trial."

Answered by AI

Are there any current recruitment efforts for this clinical experiment?

"Affirmative. Details available on clinicaltrials.gov allude to the fact that, as of February 28th 2022, this medical trial is still looking for participants with 40 people needed from 2 different locations. The study was initially made public on March 15th 2020."

Answered by AI
~0 spots leftby Apr 2024